Table of Contents
1 Table Of Contents 2 1.1 List of Tables 5 1.2 List of Figures 6 2
Executive Summary 7 3 Coronary Stents Market Overview 8 3.1
Introduction and Definition 8 3.1.1 Coronary Stents 8 3.1.1.1 Bare
Metal Stents 8 3.1.1.2 Drug Eluting Coronary Stents 8 3.2 Market
Overview 9 3.2.1 Risk Factors for Coronary Disease 12 3.2.2 Conditions
Required for Stenting 12 3.3 Cross Category Analysis 13 3.3.1 Europe
Interventional Cardiology Market Cross Category Analysis (2001-2015) 13
3.4 Competitive Landscape 14 3.5 The Europe Coronary Stent Market: Trend
Analysis 16 3.5.1 Market Snapshot 16 3.5.2 Emergence of DES - Overview
16 3.5.2.1 Drug Eluting Stent (DES) Market: Drivers 17 3.5.2.2 Drug
Eluting Stent (DES) Market: Restraints 18 3.5.3 Stent Coatings 18
3.5.4 Stent Implantation Procedure - Overview 19 3.5.5 Key End Users
20 3.5.6 The Europe Coronary Stent Market: Key Challenges 20 3.5.7 The
Europe Coronary Stent Market: Drivers 20 3.5.7.1 Developments in Imaging:
Enhanced Accuracy of Implantation and Surgical Procedures 21 3.5.7.2
Increased obesity rates in some population groups enhances the demand for
Percutaneous Coronary Intervention (PCI) 21 3.5.7.3 Affordability of BMS
drives the growth for stenting procedures in Europe 21 3.5.7.4 Minimally
invasive surgery increasing demand for overall stenting procedures 21
3.5.7.5 The Next Generation of Hybrid Devices Could Increase Treatment Outcome
and Device Applicability 22 3.5.7.6 Growing patient awareness drives
uptake for overall stenting procedures 22 3.5.8 The Europe Coronary Stent
Market: Restraints 22 3.5.8.1 Alternative treatment options creating a
threat to the usage of coronary stents 22 3.5.8.2 Negative Publicity
Related To Stent Market Have Affected the Usage of DES 22 3.5.8.3
Consolidation of the Market Creates Barriers to Entry for Small Companies
Limiting Growth 23 3.5.9 Emerging Technologies in the Europe Coronary
Stent Market 24 3.5.9.1 Diamond like Carbon Coating (DLC) 24 3.5.9.2
Advanced Drug eluting coatings 24 3.5.9.3 Bioabsorbable Stents 24
3.5.9.4 Platinum Enriched Stainless Steel (PERSE) 26 3.5.9.5 Antibody
coated or gene therapy stents 26 3.6 Future Outlook and Implications:
Europe Coronary Stent Market 26 4 Mergers & Acquisitions 27 4.1
Mergers & Acquisitions in 2009 27 4.1.1 Boston Scientific Acquires Labcoat
27 4.2 Mergers & Acquisitions in 2007 27 4.2.1 Medtronic Acquires
Setagon 27 4.3 Mergers & Acquisitions in 2006 27 4.3.1 Abbott
Laboratories Acquires Vascular Business of Guidant From Boston Scientific
27 5 Coronary Stent Pipeline Products: Europe 28 5.1 Key Coronary
Stent pipeline products 28 6 Appendix 39 6.1 Research Methodology
39 6.2 Coverage 40 6.3 Secondary Research 41 6.4 Primary Research
41 6.5 Models 42 6.6 Forecasts 42 6.7 Expert Panels 42 6.8
GlobalData Consulting 43 6.9 Contact Us 43 6.10 Disclaimer 43
1.1 List of Tables Table 1: Coronary Stent Market, Europe, Overall Revenue
($ mn), Historic, 2001 - 2008 11 Table 2: Coronary Stent Market, Europe,
Overall Revenue ($ mn), Forecast, 2008 - 2015 12 Table 3: Company Share in
the Europe Coronary Stent Market ($ mn) and (%), 2007 15 Table 4:
Drug-Eluting Stents Comparison 17 Table 5: Coatings on Drug Eluting Stents
19 Table 6: Key Companies with Bioabsorbable Stents in Pipeline 25
Table 7: Coronary Stent Pipeline Products By Equipment Type 28 Table 8:
Coronary Stent Pipeline Products By Development Stage 30 Table 9: Coronary
Stent Pipeline Products By Therapy Area 33 1.2 List of Figures
Figure 1: Coronary Stents Market Definition, Europe, 2008 8 Figure 2:
Segment Contribution By Type Of Coronary Stent (%), Europe, 2008 10 Figure
3: Coronary Stent Market, Europe, Overall Revenue ($ mn), 2001 - 2015 11
Figure 4: Europe Interventional Cardiology Market Cross Category Analysis
(2001-2015) 13 Figure 5: Company Share in the Europe Coronary Stent Market
(%), 2007 14 Figure 6: History of Coronary Artery Disease Prevention,
Europe, 2008 16 Figure 7: Diagrammatic Representation of Artery Before and
After Placing the Stent 20 Figure 8: Drivers and Restraints in the Europe
Coronary Stent Market 23 Figure 9: GlobalData Methodology 40
|